Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparison
Version of Record online: 30 DEC 2003
Copyright © 1997 by the American Association for the Study of Liver Diseases
Volume 26, Issue 6, pages 1640–1645, December 1997
How to Cite
Tong, M. J., Blatt, L. M., McHutchison, J. G., Co, R. L. and Conrad, A. (1997), Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparison. Hepatology, 26: 1640–1645. doi: 10.1002/hep.510260637
- Issue online: 30 DEC 2003
- Version of Record online: 30 DEC 2003
- 4An update on liver transplantation in the United States: recipient characteristics and outcome. In: TerasakiPI, CeckaJM, eds. Clinical Transplants. Los Angeles: UCLA Tissue Typing Laboratory, 1995: 19–33., , .
- 12Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 1995; 221: 1050–1056., , , , , , , et al.
- 17Epidemiology for public health practice. Gaithers-burg, MD: Aspen, 1996., .
- 22Kinetics of changes in serum HCV RNA during interferon therapy in patients with chronic HCV infection [Abstract]. Gastroenterology 1997; 112: A1330., , , .
- 26Nonresponders to CIFN show clinically relevant improvements in liver histology [Abstract]. Gastroenterology 1997; 112: A1294., , , .